Chan Alex H P, Tan Richard P, Michael Praveesuda L, Lee Bob S L, Vanags Laura Z, Ng Martin K C, Bursill Christina A, Wise Steven G
The Heart Research Institute, Sydney, New South Wales, Australia.
Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
PLoS One. 2017 Mar 29;12(3):e0174773. doi: 10.1371/journal.pone.0174773. eCollection 2017.
Current animal models for the evaluation of synthetic grafts are lacking many of the molecular tools and transgenic studies available to other branches of biology. A mouse model of vascular grafting would allow for the study of molecular mechanisms of graft failure, including in the context of clinically relevant disease states. In this study, we comprehensively characterise a sutureless grafting model which facilitates the evaluation of synthetic grafts in the mouse carotid artery. Using conduits electrospun from polycaprolactone (PCL) we show the gradual development of a significant neointima within 28 days, found to be greatest at the anastomoses. Histological analysis showed temporal increases in smooth muscle cell and collagen content within the neointima, demonstrating its maturation. Endothelialisation of the PCL grafts, assessed by scanning electron microscopy (SEM) analysis and CD31 staining, was near complete within 28 days, together replicating two critical aspects of graft performance. To further demonstrate the potential of this mouse model, we used longitudinal non-invasive tracking of bone-marrow mononuclear cells from a transgenic mouse strain with a dual reporter construct encoding both luciferase and green fluorescent protein (GFP). This enabled characterisation of mononuclear cell homing and engraftment to PCL using bioluminescence imaging and histological staining over time (7, 14 and 28 days). We observed peak luminescence at 7 days post-graft implantation that persisted until sacrifice at 28 days. Collectively, we have established and characterised a high-throughput model of grafting that allows for the evaluation of key clinical drivers of graft performance.
目前用于评估合成移植物的动物模型缺乏许多其他生物学分支所具备的分子工具和转基因研究手段。血管移植的小鼠模型将有助于研究移植物失败的分子机制,包括在临床相关疾病状态的背景下。在本研究中,我们全面表征了一种无缝合移植模型,该模型便于在小鼠颈动脉中评估合成移植物。使用由聚己内酯(PCL)电纺而成的导管,我们显示在28天内会逐渐形成显著的新生内膜,发现在吻合处最为明显。组织学分析显示新生内膜内平滑肌细胞和胶原蛋白含量随时间增加,表明其成熟。通过扫描电子显微镜(SEM)分析和CD31染色评估,PCL移植物的内皮化在28天内接近完成,共同再现了移植物性能的两个关键方面。为了进一步证明该小鼠模型的潜力,我们使用了对来自具有编码荧光素酶和绿色荧光蛋白(GFP)的双报告基因构建体的转基因小鼠品系的骨髓单个核细胞进行纵向非侵入性追踪。这使得能够通过生物发光成像和组织学染色随时间(7天、14天和28天)表征单个核细胞向PCL的归巢和植入情况。我们观察到移植后7天出现发光峰值,一直持续到28天处死。总体而言,我们已经建立并表征了一种高通量移植模型,该模型允许评估移植物性能的关键临床驱动因素。